GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
CN1288462A
(zh)
*
|
1998-01-23 |
2001-03-21 |
法玛西雅厄普约翰美国公司 |
噁唑烷酮组合库、组合物和制备方法
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
WO1999064417A2
(en)
|
1998-06-05 |
1999-12-16 |
Astrazeneca Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19958153A1
(de)
*
|
1999-12-03 |
2001-06-07 |
Yamanouchi Pharma Co Ltd |
Oxazolidinon-Derivate
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
CZ2003228A3
(cs)
*
|
2000-07-17 |
2003-06-18 |
Ranbaxy Laboratories Limited |
Oxazolidinonové deriváty jako antimikrobiální látky
|
WO2003008389A1
(en)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
ATE321024T1
(de)
|
2000-10-17 |
2006-04-15 |
Pharmacia & Upjohn Co Llc |
Verfahren zur herstellung von oxazolidinonverbindungen
|
US7160912B2
(en)
*
|
2000-12-26 |
2007-01-09 |
Dr.Reddy's Laboratories Ltd. |
Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
|
SE0100326D0
(sv)
|
2001-02-02 |
2001-02-02 |
Astrazeneca Ab |
New compounds
|
WO2002064574A2
(en)
*
|
2001-02-07 |
2002-08-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
|
MXPA03009643A
(es)
*
|
2001-04-20 |
2004-05-21 |
Upjohn Co |
Un metodo para la preparacion de oxazolidinonas.
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US6956040B2
(en)
*
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
CA2483600A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Ranbaxy Laboratories Limited |
Polymorphic forms of phenyl oxazolidinone derivatives
|
AU2003259159A1
(en)
|
2002-08-12 |
2004-02-25 |
Pharmacia & Upjohn Company Llc |
N-aryl-2-oxazolidinones and their derivatives
|
WO2004026848A1
(en)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
CA2502017A1
(en)
|
2002-11-21 |
2004-06-03 |
Pharmacia & Upjohn Company Llc |
N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
US7715789B2
(en)
*
|
2005-01-20 |
2010-05-11 |
Song park |
Method and apparatus mechanically providing and/or using modulated audio effects into the interior of human flesh
|
EP1685841A1
(de)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
WO2007004049A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Pharmacia & Upjohn Company Llc |
Oxazolidinones containing azetidine as antibacterial agents
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
CA2624310C
(en)
|
2005-10-04 |
2014-01-07 |
Bayer Healthcare Ag |
Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
KR20080110877A
(ko)
|
2006-03-31 |
2008-12-19 |
재단법인 이쯔우 연구소 |
헤테로환을 갖는 신규 화합물
|
US8841334B2
(en)
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
JP2009538933A
(ja)
|
2006-05-31 |
2009-11-12 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての化合物およびその使用
|
BRPI0712720A2
(pt)
|
2006-05-31 |
2012-11-20 |
Abbott Lab |
compostos tiazàis como ligantes do receptor canabinàide e usos dos mesmos
|
EP2099299A4
(de)
*
|
2006-10-23 |
2011-11-30 |
Concert Pharmaceuticals Inc |
Oxazolidinon-derivate und verfahren zu ihrer verwendung
|
US8796267B2
(en)
*
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
AU2008226947B2
(en)
|
2007-03-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
EP2142522A1
(de)
|
2007-03-28 |
2010-01-13 |
Abbott Laboratories |
1,3-thiazol-2(3h)-ylidene verbindungen als cannabinoid rezeptor liganden
|
US8501794B2
(en)
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
CA2683086A1
(en)
|
2007-05-18 |
2008-11-18 |
Abbott Laboratories |
Color tunable light source
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
US8530646B2
(en)
|
2007-10-02 |
2013-09-10 |
Research Foundation Itsuu Laboratory |
Oxazolidinone derivative having 7-membered hetero ring
|
US9193713B2
(en)
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US8058293B2
(en)
|
2008-03-11 |
2011-11-15 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
JP5554319B2
(ja)
|
2008-04-01 |
2014-07-23 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
テトラヒドロイソキノリン類、それを含む医薬組成物および治療におけるそれの使用
|
US8354557B2
(en)
*
|
2008-06-17 |
2013-01-15 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
EP2138178A1
(de)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninone zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) und/oder Asthma
|
EP2140866A1
(de)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts
|
US8173687B2
(en)
|
2008-08-15 |
2012-05-08 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8846730B2
(en)
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
ES2477552T3
(es)
*
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
TW201016692A
(en)
|
2008-09-16 |
2010-05-01 |
Abbott Lab |
Novel compounds as cannabinoid receptor ligands
|
WO2010045402A1
(en)
|
2008-10-17 |
2010-04-22 |
Abbott Laboratories |
Trpv1 antagonists
|
CN102186836A
(zh)
|
2008-10-17 |
2011-09-14 |
雅培制药有限公司 |
Trpv1拮抗剂
|
WO2010062308A1
(en)
|
2008-10-28 |
2010-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
US8557983B2
(en)
|
2008-12-04 |
2013-10-15 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
US8586754B2
(en)
|
2008-12-05 |
2013-11-19 |
Abbvie Inc. |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
MX2011005922A
(es)
|
2008-12-05 |
2011-06-16 |
Abbott Lab |
Derivados de sulfonamida como agentes inductores de apoptosis selectiva de bcl-2 para el tratamiento del cancer y enfermedades inmunes.
|
PA8854001A1
(es)
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
CN106045893A
(zh)
|
2009-01-19 |
2016-10-26 |
Abbvie 公司 |
用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂
|
CA2747837A1
(en)
|
2009-01-19 |
2010-07-22 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
US8841296B2
(en)
*
|
2009-03-27 |
2014-09-23 |
Council of Scientific and Industrial Research, Anusandhan Bhawan, Rafi Marg |
Substituted 1, 4-dioxa-8-azaspiro[4,5]decanes useful as fungicides and a process for the preparation thereof
|
CA2756178A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2010111573A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
EP2411371B1
(de)
|
2009-03-27 |
2015-05-20 |
AbbVie Inc. |
Verbindungen als cannabinoidrezeptorliganden
|
US8507493B2
(en)
|
2009-04-20 |
2013-08-13 |
Abbvie Inc. |
Amide and amidine derivatives and uses thereof
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
US20220315555A1
(en)
|
2009-05-26 |
2022-10-06 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US9034875B2
(en)
|
2009-05-26 |
2015-05-19 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
ES2546294T3
(es)
|
2009-05-26 |
2015-09-22 |
Abbvie Bahamas Ltd. |
Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias
|
US8962639B2
(en)
|
2009-05-29 |
2015-02-24 |
Abbvie Inc. |
Potassium channel modulators
|
WO2011053740A1
(en)
|
2009-10-28 |
2011-05-05 |
Belkin International, Inc. |
Portable multi-media communication device protective carrier and method of manufacture therefor
|
MX2012006036A
(es)
|
2009-11-25 |
2012-06-19 |
Abbott Lab |
Moduladores del canal del calcio.
|
TW201130855A
(en)
|
2009-12-16 |
2011-09-16 |
Abbott Lab |
Prodrug compounds useful as cannabinoid ligands
|
RU2568611C2
(ru)
|
2010-03-25 |
2015-11-20 |
Эббви Инк. |
Средства, индуцирующие апоптоз, для лечения рака, иммунных и аутоиммунных заболеваний
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
US8586596B2
(en)
|
2010-06-15 |
2013-11-19 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
AU2010359001A1
(en)
|
2010-08-10 |
2013-03-14 |
Abbvie Inc. |
Novel TRPV3 modulators
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
JP5998142B2
(ja)
|
2010-09-27 |
2016-09-28 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
複素環化合物およびグリコーゲンシンターゼキナーゼ−3阻害薬としてのその使用
|
BR112013009093B1
(pt)
|
2010-10-29 |
2022-04-19 |
Abbvie Inc |
Processo para a preparação de uma dispersão sólida contendo um agente indutor de apoptose
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
SG10202010119TA
(en)
|
2010-11-15 |
2020-11-27 |
Abbvie Inc |
NAMPT And Rock Inhibitors
|
WO2012067963A1
(en)
|
2010-11-15 |
2012-05-24 |
Abbott Laboratories |
Nampt inhibitors
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
WO2012067824A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Potassium channel modulators
|
NO2643322T3
(de)
|
2010-11-23 |
2018-01-27 |
|
|
RU2593231C2
(ru)
|
2010-11-23 |
2016-08-10 |
ЭббВи Айэленд Анлимитед Компани |
Способы лечения с использованием селективных ингибиторов bcl-2
|
WO2012082992A1
(en)
*
|
2010-12-15 |
2012-06-21 |
Biovista, Inc. |
Compositions and methods for cancer treatment
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
US8802693B1
(en)
|
2011-03-09 |
2014-08-12 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
WO2012129491A1
(en)
|
2011-03-24 |
2012-09-27 |
Abbott Laboratories |
Trpv3 modulators
|
CN103635458B
(zh)
|
2011-03-25 |
2016-10-19 |
艾伯维公司 |
Trpv1拮抗剂
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012158399A1
(en)
|
2011-05-13 |
2012-11-22 |
Abbott Laboratories |
Condensed 2 - carbamoylpyridazinones as potassium channel modulators
|
EP2739614B1
(de)
|
2011-08-05 |
2017-02-22 |
AbbVie Deutschland GmbH & Co KG |
Aminochromanderivate, pharmazeutische zusammensetzungen davon und ihre therapeutische verwendung
|
TWI561521B
(en)
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TWI571466B
(zh)
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
US8772499B2
(en)
|
2011-10-24 |
2014-07-08 |
Abbvie Inc. |
TRPV3 modulators
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
WO2013072520A1
(en)
|
2011-11-18 |
2013-05-23 |
AbbVie Deutschland GmbH & Co. KG |
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8969325B2
(en)
|
2011-12-19 |
2015-03-03 |
Abbvie Inc. |
TRPV1 antagonists
|
US8859584B2
(en)
|
2011-12-19 |
2014-10-14 |
Abbvie, Inc. |
TRPV1 antagonists
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013149376A1
(en)
|
2012-04-02 |
2013-10-10 |
Abbott Laboratories |
Chemokine receptor antagonists
|
WO2013155695A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbott Laboratories |
Isoindolone derivatives
|
EP2850081A1
(de)
|
2012-05-11 |
2015-03-25 |
AbbVie Inc. |
Thiazolcarboxamidderivate zur verwendung als nampt-hemmer
|
PE20150224A1
(es)
|
2012-05-11 |
2015-03-08 |
Abbvie Inc |
Inhibidores del nampt
|
AR091023A1
(es)
|
2012-05-11 |
2014-12-30 |
Abbvie Inc |
Inhibidores del nampt
|
EP2852585A1
(de)
|
2012-05-11 |
2015-04-01 |
AbbVie Inc. |
Nampt-inhibitoren
|
US20130317055A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
US20130317054A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
AU2012382373A1
(en)
|
2012-06-12 |
2014-12-11 |
Abbvie Inc. |
Pyridinone and pyridazinone derivatives
|
US8796328B2
(en)
|
2012-06-20 |
2014-08-05 |
Abbvie Inc. |
TRPV1 antagonists
|
SG11201501894VA
(en)
|
2012-09-14 |
2015-04-29 |
Abbvie Inc |
Tricyclic quinoline and quinoxaline derivatives
|
US20140080813A1
(en)
|
2012-09-14 |
2014-03-20 |
AbbVie Deutschland GmbH & Co. KG |
Tricyclic quinoline and quinoxaline derivatives
|
JP2016516710A
(ja)
|
2013-03-13 |
2016-06-09 |
アッヴィ・インコーポレイテッド |
ピリジン系cdk9キナーゼ阻害薬
|
EP2970268A1
(de)
|
2013-03-13 |
2016-01-20 |
AbbVie Inc. |
Cdk9-kinase-hemmer
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
WO2014140184A1
(en)
|
2013-03-14 |
2014-09-18 |
AbbVie Deutschland GmbH & Co. KG |
Novel inhibitor compounds of phosphodiesterase type 10a
|
BR112015023016A2
(pt)
|
2013-03-14 |
2017-07-18 |
Abbvie Deutschland |
derivados de oxindolo carregando um substituinte oxetano e uso do mesmo para tratamento de doenças relacionadas a vasopressina
|
CA2903538A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
Pyrrolopyrimindine cdk9 kinase inhibitors
|
CA2905530A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
|
WO2014151444A1
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
|
US20140275082A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
AU2014336153A1
(en)
|
2013-10-17 |
2016-04-28 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2015055771A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9840495B2
(en)
|
2013-12-20 |
2017-12-12 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
|
US9328112B2
(en)
|
2014-02-06 |
2016-05-03 |
Abbvie Inc. |
Tetracyclic CDK9 kinase inhibitors
|
US9527856B2
(en)
|
2014-05-15 |
2016-12-27 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
|
EP3191459A1
(de)
|
2014-09-05 |
2017-07-19 |
AbbVie Deutschland GmbH & Co. KG |
Kondensierte heterocyclischen oder carbocyclischen verbindungen mit substituierten cycloaliphatischen rest und verwendung zur behandlung von vasopressin-erkrankungen
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
CN104327004A
(zh)
*
|
2014-11-17 |
2015-02-04 |
重庆华邦制药有限公司 |
高纯度利奈唑胺氮氧化物的制备方法
|
WO2016160938A1
(en)
|
2015-04-02 |
2016-10-06 |
Abbvie Inc. |
N-(1,3-thiazol-2-yl)pyrimidine-5-carboxamides as trpv3 modulators
|
WO2017089458A1
(en)
|
2015-11-25 |
2017-06-01 |
AbbVie Deutschland GmbH & Co. KG |
Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders
|
US10835535B2
(en)
|
2016-05-07 |
2020-11-17 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Certain protein kinase inhibitors
|
US11168078B2
(en)
|
2016-11-28 |
2021-11-09 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
|
US9859219B1
(en)
|
2017-01-24 |
2018-01-02 |
International Business Machines Corporation |
Copper wiring structures with copper titanium encapsulation
|
WO2018175449A1
(en)
|
2017-03-21 |
2018-09-27 |
AbbVie Deutschland GmbH & Co. KG |
Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radical
|
SI3612531T1
(sl)
|
2017-04-18 |
2022-11-30 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sredstva, ki sprožajo apoptozo
|
WO2019174598A1
(en)
|
2018-03-14 |
2019-09-19 |
Fochon Pharmaceuticals, Ltd. |
SUBSTITUTED (2-AZABICYCLO [3.1.0] HEXAN-2-YL) PYRAZOLO [1, 5-a] PYRIMIDINE AND IMIDAZO [1, 2-b] PYRIDAZINE COMPOUNDS AS TRK KINASES INHIBITORS
|
US11485707B2
(en)
|
2018-03-23 |
2022-11-01 |
Fochon Pharmaceuticals, Ltd. |
Deuterated compounds as rock inhibitors
|
WO2020234636A1
(en)
|
2019-05-17 |
2020-11-26 |
Cadila Healthcare Limited |
Novel compounds for the treatment of mammalian infections
|
US11608320B2
(en)
|
2020-02-02 |
2023-03-21 |
Kuwait University |
Oxazolidinone hydroxamic acid derivatives
|